Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

Co-primary efficacy in RAS G12–mutant PDAC included statistically significant OS and PFS gains assessed by blinded ...

The RAS family commonly drives the growth and survival of human cancers. Mutations in KRAS, NRAS, and HRAS occur in approximately 20% of all human cancers, including solid tumors, such as pancreatic, ...

What's your checking account balance? Your credit score? The top personal finance apps we've tested can give you the answers in seconds. We help you choose the right one to take control of your money.

The top video conferencing services we've tested help you stay connected and communicate with clients, team members, and anyone else, no matter where you are. I've been writing about technology for ...